Page results
-
UCLH and UCL neurologists have published the first clinical observations of patients who experienced an ischaemic stroke, the most common form of stroke, following an Oxford AstraZeneca vaccine.
-
A BBC One documentary featuring clinicians at UCLH which airs this Thursday highlights the harm to the body and brain caused by ultra-processed food.
-
More people with dementia in the UK will be able to take part in research and help accelerate the development of new treatments, as the Government announces £49.9 million of new funding to build a network of dementia trials sites across the country.
-
Five cases of Alzheimer’s disease are believed to have arisen as a result of medical treatments decades earlier, reports a team of UCL and UCLH researchers.
-
Prime Minister Boris Johnson visited the vaccination centre at the Islington Business Design Centre yesterday.
-
Researchers at UCLH and Imperial College Healthcare NHS Trust are to trial a new weight loss treatment which involves reducing blood supply to part of the stomach.
-
Our neonatal service is a recognised centre of excellence caring for acutely ill and preterm babies from our local area and beyond.
-
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
-
UCLH is to lead an initiative to improve care for myeloma patients alongside Oxford University Hospitals NHS Foundation Trust (OUH) and University Hospital Southampton NHS Foundation Trust (UHS).
-
At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.
File results
-
FOI/2024/0097 - Laboratory Information Management System (LIMS)/ pathology IT system
-
FOI/2024/0101 - Immunoglobulin drug treatments
-
FOI/2024/0108 - Clinical letters/ EPR, PAS, patient portal systems, hybrid mail contract
-
FOI/2024/0112 - Fertility treatment in 2021
-
FOI/2024/0116 - Patient treatment due to noise levels of the London Underground
-
FOI/2024/0121 - Migraine treatments
-
FOI/2024/0126 - Ophthalmology RTT pathway
-
FOI/2024/0128 - Post mortem cardiac device interrogation
-
FOI/2024/0129 - Nursing associate and anaesthesia associate staffing
-
FOI/2024/0131 - Alpha-1 Proteinase-Inhibitor (AAT) purchased in 2023